UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report: May 11, 2007
Spectrum Pharmaceuticals, Inc.
(Exact name of Registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-28782
|
|
93-0979187 |
(State or other jurisdiction
|
|
(Commission File
|
|
(I.R.S. Employer |
of incorporation)
|
|
Number)
|
|
Identification No.) |
|
|
|
157 Technology Drive |
|
|
Irvine, California
|
|
92618 |
(Address of principal executive offices)
|
|
(Zip Code) |
(949) 788-6700
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 8.01. Other Events.
On May 11, 2007, Spectrum Pharmaceuticals, Inc. (the Company) issued a press concerning the
completion of the previously announced sale of 5,134,100 shares of common stock at a price of $6.25
per share. The net proceeds to the Company from the offering, after placement agent fees and
estimated expenses, are approximately $30 million. The Company had approximately $73 million in
cash, cash equivalents and marketable securities and approximately 31 million shares of common
stock issued and outstanding as of May 10, 2007 following the equity offering.
A copy of the press release is filed as Exhibit 99.1 to this report and incorporated herein by
reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
Exhibit No. |
|
Description |
99.1
|
|
Press release dated May 11, 2007. |
2